Description
Cartalax is a short research peptide studied in organ-system and tissue-specific signaling models. Ridge Peptides supplies it as a lyophilized powder with lot-level third-party verification.
How Cartalax Is Used in Research
Laboratory studies of Cartalax focus on tissue-specific signaling pathways in cell-culture and preclinical models. The material is not a drug and carries no therapeutic indication.
Cartalax Specifications
| Compound | Cartalax |
|---|---|
| Form | Lyophilized powder |
| Vial size | 20MG |
| Purity documentation | Independent third-party testing — COA per lot |
| Origin | USA — manufacturing & quality control |
| Storage | Sealed, -20°C, protected from light |
| Reconstitution | Research solvents only (not included) |
Cartalax Certificate of Analysis
Every lot of Cartalax is screened by an independent laboratory for identity and purity before release. Your COA ships with the order and can be re-issued at any time by quoting the lot number on your vial label.
Cartalax Frequently Asked Questions
How should Cartalax be stored?
Keep the lyophilized vial sealed, protected from light, and frozen for long-term stability. Avoid repeated temperature swings and handle according to your institution’s protocols.
Is Cartalax for human use?
No. Cartalax is sold strictly for laboratory research. Human or animal consumption is prohibited, and no medical use is claimed.
Can I request the Certificate of Analysis?
Yes — every lot is third-party tested. Provide your order number or batch/lot code through our contact page and we will send the COA.
Research use only. Not for human or animal consumption, diagnostic, cosmetic, or therapeutic use. Products and statements have not been evaluated by the FDA. Sold exclusively for laboratory research in compliance with applicable law.
Reviews
There are no reviews yet.